Drawing for ARTECOM

USPTO serial 77639593

ARTECOM

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
KAJUBI, ELIZABETH N
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ARTECOM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Angelo Notaro

ANGELO NOTARO NOTARO & MICHALOS P.C.100 DUTCH HILL RD STE 110ORANGEBURG, NY 10962-2107UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Antimalarial preparations for oral use or injectableABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 29, 2009MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Jul 29, 2009ABN5ABANDONMENT - AFTER PUBLICATION—
Jul 25, 2009EXARTEAS EXPRESS ABANDONMENT RECEIVED—
May 18, 2009ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 28, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 8, 2009NPUBNOTICE OF PUBLICATION—
Mar 23, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 23, 2009ALIEASSIGNED TO LIE—
Mar 23, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 17, 2009DOCKASSIGNED TO EXAMINER—
Dec 29, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance